Rocket Pharmaceuticals In...

NASDAQ: RCKT · Real-Time Price · USD
3.04
0.01 (0.33%)
At close: Aug 15, 2025, 3:59 PM
3.02
-0.68%
After-hours: Aug 15, 2025, 07:30 PM EDT

Rocket Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 9.19M n/a n/a n/a 10.31M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
2.54M 2.99M n/a 2.39M 2.34M 2.25M 5.16M 1.76M 1.72M 1.67M 1.78M 1.64M 1.57M 1.3M 3.19M 800K 700K 674K
Gross Profit
-2.54M -2.99M 4.59M -2.39M -2.34M -2.25M 5.16M -1.76M -1.72M -1.67M -1.78M -1.64M -1.57M -1.3M -3.19M -800K -700K -674K
Operating Income
-71.15M -64.39M -62.69M -69.42M -73.71M -67.38M -63.28M -65.43M -68.76M -62.19M -69.08M -58.49M -54.21M -42.56M -44.33M -49.65M -34.05M -39.22M
Interest Income
2.7M 3.53M 2.84M 3.18M 4.54M 5.79M 4.09M 4M 3.52M 4.33M 2.33M 1.35M 669K 623K 849K 806K 501K 272K
Pretax Income
-68.92M -61.33M -60.33M -66.72M -69.65M -62.05M -59.66M -61.9M -65.7M -58.34M -66.72M -57.76M -54.4M -42.98M -44.25M -50.12M -34.52M -40.18M
Net Income
-68.92M -61.33M -60.33M -66.72M -69.65M -62.05M -59.66M -61.9M -65.7M -54.94M -64.36M -57.02M -54.59M -43.4M -44.25M -50.12M -34.52M -40.18M
Selling & General & Admin
25.02M 28.45M 25.34M 27.11M 26.58M 21.36M 21.54M 18.59M 17.37M 15.82M 19.05M 15.11M 12.85M 11.77M 12.17M 9.67M 9.25M 10.68M
Research & Development
42.66M 35.94M 37.36M 42.31M 44.79M 43.76M 41.74M 46.84M 51.38M 46.37M 50.04M 43.38M 41.36M 30.79M 32.16M 39.98M 24.8M 28.54M
Other Expenses
3.47M n/a n/a n/a n/a n/a n/a n/a n/a n/a -500K n/a n/a n/a -500K n/a n/a 500K
Operating Expenses
71.15M 64.39M 62.69M 69.42M 71.37M 65.12M 63.28M 65.43M 68.76M 62.19M 68.58M 58.49M 54.21M 42.56M 43.83M 49.65M 34.05M 38.72M
Interest Expense
473K 472K 473K 471K 471K 471K 470K 469K 468K 468K 467K 621K 861K 1.04M 1.26M 1.28M 978K 1.73M
Selling & Marketing Expenses
n/a n/a n/a n/a -786K -787K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
71.15M 64.39M 62.69M 69.42M 73.71M 67.38M 63.28M 65.43M 68.76M 62.19M 68.58M 58.49M 54.21M 42.56M 43.83M 49.65M 34.05M 38.72M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -3.39M -2.36M -732K 192K 418K n/a n/a 251K n/a
Shares Outstanding (Basic)
111.02M 110.09M 97.53M 94.16M 93.75M 93.55M 93.34M 82.64M 80.47M 79.45M 72.89M 66.22M 65.48M 64.51M 64.47M 63.83M 63.06M 61.57M
Shares Outstanding (Diluted)
111.02M 110.09M 97.53M 94.16M 93.75M 93.55M 93.34M 82.64M 80.47M 79.45M 72.89M 66.22M 65.48M 64.51M 64.47M 63.83M 63.06M 61.57M
EPS (Basic)
-0.62 -0.56 -0.62 -0.71 -0.74 -0.66 -0.64 -0.75 -0.82 -0.69 -0.88 -0.86 -0.83 -0.67 -0.69 -0.79 -0.55 -0.65
EPS (Diluted)
-0.62 -0.56 -0.62 -0.71 -0.74 -0.66 -0.64 -0.75 -0.82 -0.69 -0.88 -0.86 -0.83 -0.67 -0.69 -0.79 -0.55 -0.65
EBITDA
-65.87M -57.87M -57.49M -63.86M -66.84M -59.33M -56.82M -59.67M -63.51M -56.19M -64.98M -55.66M -52.37M -41.22M -41.1M -48.78M -32.84M -37.78M
EBIT
-68.45M -60.86M -59.85M -66.25M -69.17M -61.58M -59.19M -61.43M -65.23M -57.87M -66.75M -57.13M -53.54M -41.94M -44.28M -48.84M -33.55M -37.81M
Depreciation & Amortization
2.58M 2.99M 2.36M 2.39M 2.34M 2.25M 2.37M 1.76M 1.72M 1.67M 1.78M 1.64M 1.57M 1.3M 3.19M 800K 700K 674K